nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—AOC1—blood plasma—abdominal aortic aneurysm	0.0529	0.127	CbGeAlD
Amiloride—SLC9A1—blood plasma—abdominal aortic aneurysm	0.0507	0.122	CbGeAlD
Amiloride—PLAU—blood plasma—abdominal aortic aneurysm	0.0481	0.116	CbGeAlD
Amiloride—PLAU—amb2 Integrin signaling—LRP1—abdominal aortic aneurysm	0.0415	0.071	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—LRP1—abdominal aortic aneurysm	0.0334	0.0571	CbGpPWpGaD
Amiloride—AOC1—connective tissue—abdominal aortic aneurysm	0.0282	0.0679	CbGeAlD
Amiloride—SLC9A1—connective tissue—abdominal aortic aneurysm	0.027	0.065	CbGeAlD
Amiloride—PLAU—Dissolution of Fibrin Clot—SERPINE1—abdominal aortic aneurysm	0.0263	0.045	CbGpPWpGaD
Amiloride—PLAU—connective tissue—abdominal aortic aneurysm	0.0256	0.0616	CbGeAlD
Amiloride—SCNN1G—kidney—abdominal aortic aneurysm	0.0244	0.0589	CbGeAlD
Amiloride—AOC1—kidney—abdominal aortic aneurysm	0.024	0.0578	CbGeAlD
Amiloride—SLC9A1—kidney—abdominal aortic aneurysm	0.023	0.0553	CbGeAlD
Amiloride—PLAU—kidney—abdominal aortic aneurysm	0.0218	0.0525	CbGeAlD
Amiloride—SCNN1B—kidney—abdominal aortic aneurysm	0.0206	0.0497	CbGeAlD
Amiloride—PLAU—Osteopontin Signaling—MMP9—abdominal aortic aneurysm	0.0201	0.0344	CbGpPWpGaD
Amiloride—PLAU—Osteopontin Signaling—NFKB1—abdominal aortic aneurysm	0.0199	0.0341	CbGpPWpGaD
Amiloride—SCNN1A—kidney—abdominal aortic aneurysm	0.0191	0.0459	CbGeAlD
Amiloride—ASIC1—spinal cord—abdominal aortic aneurysm	0.0187	0.045	CbGeAlD
Amiloride—PLAU—Wnt Signaling Pathway—LDLR—abdominal aortic aneurysm	0.0174	0.0298	CbGpPWpGaD
Amiloride—PLAU—Blood Clotting Cascade—SERPINE1—abdominal aortic aneurysm	0.0173	0.0295	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—abdominal aortic aneurysm	0.017	0.029	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—NOS2—abdominal aortic aneurysm	0.0157	0.0268	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—MMP14—abdominal aortic aneurysm	0.0138	0.0236	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—MMP2—abdominal aortic aneurysm	0.0134	0.0229	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—MMP2—abdominal aortic aneurysm	0.013	0.0223	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—LDLR—abdominal aortic aneurysm	0.0125	0.0213	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—abdominal aortic aneurysm	0.0122	0.0209	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—LDLR—abdominal aortic aneurysm	0.0118	0.0202	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—abdominal aortic aneurysm	0.0116	0.0198	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—PTGS2—abdominal aortic aneurysm	0.0115	0.0197	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—abdominal aortic aneurysm	0.0106	0.0182	CbGpPWpGaD
Amiloride—SLC22A2—kidney—abdominal aortic aneurysm	0.0103	0.0248	CbGeAlD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—abdominal aortic aneurysm	0.0103	0.0176	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—MMP9—abdominal aortic aneurysm	0.01	0.0172	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—NFKB1—abdominal aortic aneurysm	0.00994	0.017	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—MMP9—abdominal aortic aneurysm	0.0098	0.0168	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—NFKB1—abdominal aortic aneurysm	0.00969	0.0166	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—NOS2—abdominal aortic aneurysm	0.00931	0.0159	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—AGT—abdominal aortic aneurysm	0.00889	0.0152	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—abdominal aortic aneurysm	0.00872	0.0149	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—MMP2—abdominal aortic aneurysm	0.00799	0.0137	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—abdominal aortic aneurysm	0.00788	0.0135	CbGpPWpGaD
Amiloride—PLAU—Complement and Coagulation Cascades—SERPINE1—abdominal aortic aneurysm	0.00784	0.0134	CbGpPWpGaD
Amiloride—SLC22A4—kidney—abdominal aortic aneurysm	0.00764	0.0184	CbGeAlD
Amiloride—ASIC2—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00761	0.013	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—AAAS—abdominal aortic aneurysm	0.0075	0.0128	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00748	0.0128	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—SOD2—abdominal aortic aneurysm	0.00746	0.0128	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CCL2—abdominal aortic aneurysm	0.00732	0.0125	CbGpPWpGaD
Amiloride—SLC22A1—kidney—abdominal aortic aneurysm	0.00728	0.0175	CbGeAlD
Amiloride—PLAU—E2F transcription factor network—SERPINE1—abdominal aortic aneurysm	0.00661	0.0113	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—MMP9—abdominal aortic aneurysm	0.00645	0.011	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.00639	0.0109	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—CDKN2A—abdominal aortic aneurysm	0.00617	0.0106	CbGpPWpGaD
Amiloride—SLC22A4—spinal cord—abdominal aortic aneurysm	0.00595	0.0143	CbGeAlD
Amiloride—SCNN1D—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00576	0.00986	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00576	0.00986	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00576	0.00986	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00576	0.00986	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00576	0.00986	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—MMP9—abdominal aortic aneurysm	0.00563	0.00962	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—MMP9—abdominal aortic aneurysm	0.00524	0.00896	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—SERPINE1—abdominal aortic aneurysm	0.00494	0.00845	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SELL—abdominal aortic aneurysm	0.00474	0.0081	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN2A—abdominal aortic aneurysm	0.00462	0.00789	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN2A—abdominal aortic aneurysm	0.00448	0.00766	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00427	0.0073	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.0038	0.0065	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—NFKB1—abdominal aortic aneurysm	0.00364	0.00622	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00342	0.00585	CbGpPWpGaD
Amiloride—SLC9A1—Disease—LRP1—abdominal aortic aneurysm	0.00245	0.00419	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AAAS—abdominal aortic aneurysm	0.00213	0.00363	CbGpPWpGaD
Amiloride—SLC9A1—Disease—LDLR—abdominal aortic aneurysm	0.00186	0.00317	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AAAS—abdominal aortic aneurysm	0.00178	0.00304	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00174	0.00297	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NCF1—abdominal aortic aneurysm	0.00174	0.00297	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS2—abdominal aortic aneurysm	0.00167	0.00285	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00162	0.00277	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LDLR—abdominal aortic aneurysm	0.00155	0.00266	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00151	0.00258	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.0014	0.0024	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOE—abdominal aortic aneurysm	0.000961	0.00164	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS2—abdominal aortic aneurysm	0.000895	0.00153	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000823	0.00141	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AGT—abdominal aortic aneurysm	0.000821	0.0014	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOE—abdominal aortic aneurysm	0.000805	0.00138	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000767	0.00131	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—abdominal aortic aneurysm	0.000754	0.00129	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—abdominal aortic aneurysm	0.000658	0.00113	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000551	0.000943	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AAAS—abdominal aortic aneurysm	0.000385	0.000659	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AAAS—abdominal aortic aneurysm	0.000359	0.000614	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LDLR—abdominal aortic aneurysm	0.000336	0.000575	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LDLR—abdominal aortic aneurysm	0.000314	0.000536	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AGT—abdominal aortic aneurysm	0.000178	0.000304	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOE—abdominal aortic aneurysm	0.000174	0.000298	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AGT—abdominal aortic aneurysm	0.000166	0.000283	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOE—abdominal aortic aneurysm	0.000162	0.000278	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—abdominal aortic aneurysm	0.000119	0.000204	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000111	0.00019	CbGpPWpGaD
